Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q4 2025 Earnings Call Transcript February 26, 2026
Operator: Good day, everyone, and welcome to the Syndax Fourth Quarter 2025 Earnings Conference Call. Today’s call is being recorded. [Operator Instructions]. At this time, I would like to turn the call over to Sharon Klahre, Head of Investor Relations at Syndax Pharmaceuticals.
Sharon Klahre: Thank you, Operator. Welcome, and thank you all for joining us today for a review of Syndax’s Fourth...
